These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 36376373)

  • 1. Hepatocellular carcinoma cells loss lenvatinib efficacy in vitro through autophagy and hypoxia response-derived neuropilin-1 degradation.
    Fernández-Palanca P; Payo-Serafín T; San-Miguel B; Méndez-Blanco C; Tuñón MJ; González-Gallego J; Mauriz JL
    Acta Pharmacol Sin; 2023 May; 44(5):1066-1082. PubMed ID: 36376373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VEGF/Nrp1/HIF-1α promotes proliferation of hepatocellular carcinoma through a positive feedback loop.
    Wang YB; Zheng KW; Hu YY; Salameen H; Zhu ZY; Wu FF; Ding X
    Med Oncol; 2023 Oct; 40(12):339. PubMed ID: 37875691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment.
    Wang M; Zhao X; Zhu D; Liu T; Liang X; Liu F; Zhang Y; Dong X; Sun B
    J Exp Clin Cancer Res; 2017 Apr; 36(1):60. PubMed ID: 28449718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticancer and Antiangiogenic Activities of Novel α-Mangostin Glycosides in Human Hepatocellular Carcinoma Cells via Downregulation of c-Met and HIF-1α.
    Kim SM; Han JM; Le TT; Sohng JK; Jung HJ
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32516967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SiRNA-HIF-1α delivered by attenuated Salmonella enhances the efficacy of Lenvatinib against hepatocellular carcinoma.
    Chen P; Wang Y; Zhu X; Huang Y; Chen J; Sun H; Wang Y; Zhao S; You Y; Wu Y; Yang T; Wei T; Duan X; Zhao T; Jia H; Ren J
    Int Immunopharmacol; 2024 Mar; 130():111728. PubMed ID: 38430801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Periostin contributes to arsenic trioxide resistance in hepatocellular carcinoma cells under hypoxia.
    Liu Y; Gao F; Song W
    Biomed Pharmacother; 2017 Apr; 88():342-348. PubMed ID: 28119236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia-mediated sorafenib resistance can be overcome by EF24 through Von Hippel-Lindau tumor suppressor-dependent HIF-1α inhibition in hepatocellular carcinoma.
    Liang Y; Zheng T; Song R; Wang J; Yin D; Wang L; Liu H; Tian L; Fang X; Meng X; Jiang H; Liu J; Liu L
    Hepatology; 2013 May; 57(5):1847-57. PubMed ID: 23299930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia upregulates Rab11-family interacting protein 4 through HIF-1α to promote the metastasis of hepatocellular carcinoma.
    Hu F; Deng X; Yang X; Jin H; Gu D; Lv X; Wang C; Zhang Y; Huo X; Shen Q; Luo Q; Zhao F; Ge T; Zhao F; Chu W; Shu H; Yao M; Fan J; Qin W
    Oncogene; 2015 Dec; 34(49):6007-17. PubMed ID: 25745995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing of hypoxia-inducible factor-1β induces anti-tumor effects in hepatoma cell lines under tumor hypoxia.
    Choi SH; Chung AR; Kang W; Park JY; Lee MS; Hwang SW; Kim DY; Kim SU; Ahn SH; Kim S; Han KH
    PLoS One; 2014; 9(7):e103304. PubMed ID: 25068796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIF-1α-activated TM4SF1-AS1 promotes the proliferation, migration, and invasion of hepatocellular carcinoma cells by enhancing TM4SF1 expression.
    Zeng Z; Shi Z; Liu Y; Zhao J; Lu Q; Guo J; Liu X; Huang D; Xu Q
    Biochem Biophys Res Commun; 2021 Aug; 566():80-86. PubMed ID: 34118595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mild chronic hypoxia-induced HIF-2α interacts with c-MYC through competition with HIF-1α to induce hepatocellular carcinoma cell proliferation.
    Mu H; Yu G; Li H; Wang M; Cui Y; Zhang T; Song T; Liu C
    Cell Oncol (Dordr); 2021 Oct; 44(5):1151-1166. PubMed ID: 34339013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cabozantinib inhibits the growth of lenvatinib-resistant hepatoma cells restoring FTCD expression.
    Fujita K; Yamada M; Morishita A; Ono M; Himoto T; Kobara H; Masaki T
    Biochem Pharmacol; 2024 Aug; 226():116321. PubMed ID: 38815631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomal microRNA profiling revealed enhanced autophagy suppression and anti-tumor effects of a combination of compound Phyllanthus urinaria and lenvatinib in hepatocellular carcinoma.
    Liao M; Qin M; Liu L; Huang H; Chen N; Du H; Huang D; Wang P; Zhou H; Tong G
    Phytomedicine; 2024 Jan; 122():155091. PubMed ID: 37844378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ADAM17 mediates hypoxia-induced drug resistance in hepatocellular carcinoma cells through activation of EGFR/PI3K/Akt pathway.
    Wang XJ; Feng CW; Li M
    Mol Cell Biochem; 2013 Aug; 380(1-2):57-66. PubMed ID: 23625205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia-induced UBE2K promotes the malignant progression of HCC.
    Ouyang G; Fu W; Guo J; Lu Q; Yao Y; Ge L; Zhao J; Zhang J; Hu X; Li S; Xu Q; Huang D; Zhang Y
    Pathol Res Pract; 2023 May; 245():154422. PubMed ID: 37003132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STOML2 potentiates metastasis of hepatocellular carcinoma by promoting PINK1-mediated mitophagy and regulates sensitivity to lenvatinib.
    Zheng Y; Huang C; Lu L; Yu K; Zhao J; Chen M; Liu L; Sun Q; Lin Z; Zheng J; Chen J; Zhang J
    J Hematol Oncol; 2021 Jan; 14(1):16. PubMed ID: 33446239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIF-1α promoted vasculogenic mimicry formation in lung adenocarcinoma through NRP1 upregulation in the hypoxic tumor microenvironment.
    Fu R; Du W; Ding Z; Wang Y; Li Y; Zhu J; Zeng Y; Zheng Y; Liu Z; Huang JA
    Cell Death Dis; 2021 Apr; 12(4):394. PubMed ID: 33850110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of COX-2 expression and epithelial-to-mesenchymal transition by hypoxia-inducible factor-1α is associated with poor prognosis in hepatocellular carcinoma patients post TACE surgery.
    Huang M; Wang L; Chen J; Bai M; Zhou C; Liu S; Lin Q
    Int J Oncol; 2016 May; 48(5):2144-54. PubMed ID: 26984380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxic Hepatocellular Carcinoma Cells Acquire Arsenic Trioxide Resistance by Upregulating HIF-1α Expression.
    Chen Y; Li H; Chen D; Jiang X; Wang W; Li D; Shan H
    Dig Dis Sci; 2022 Aug; 67(8):3806-3816. PubMed ID: 34383201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-338-3p inhibits hepatocarcinoma cells and sensitizes these cells to sorafenib by targeting hypoxia-induced factor 1α.
    Xu H; Zhao L; Fang Q; Sun J; Zhang S; Zhan C; Liu S; Zhang Y
    PLoS One; 2014; 9(12):e115565. PubMed ID: 25531114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.